related documents
- Efficacy of sublingual apomorphine (APL-130277) for the treatment of "off" episodes in patients with Parkinson's disease Conferences
- Pharmacokinetics, safety and tolerability of high-dose sub-lingually administered APL-130277 in healthy volunteers Conferences
- Pharmacokinetics, safety and tolerability of sub-lingually administered APL-130277 compared to subcutaneous apomorphine in healthy volunteers Conferences
- Safety of sublingual APL-130277 for the treatment of OFF episodes in patients with Parkinson's disease Conferences